We have explored novel synthetic routes for the preparation of chondroitin sulfate (CS) oligosaccharides that are based on the use of N-tetrachlorophthaloyl (N-TCP) and N-trifluoroacetyl (N-TFA) galactosamine building blocks. On the one hand, we have performed the total synthesis of two CS disaccharides using N-TCP units, demonstrating the compatibility of TCP protection with the final deprotection/sulfation steps. However, the 2+2 coupling of N-TCP containing disaccharides, for the synthesis of CS tetrasaccharides, failed. On the contrary, a synthetic route using N-TFA galactosamine units efficiently afforded biologically relevant CS-like oligosaccharides. The TFA groups could be easily removed at the end of the synthesis and microwave irradiation greatly facilitated the sulfation reactions. The utility of this approach was illustrated with the total synthesis of two CS-like tetrasaccharides, with different sulfate distribution. Finally, we employed a fluorescence polarization assay to estimate the relative ability of the synthesized compounds to inhibit the interaction between FGF-2 and heparin.
Introduction
Chondroitin sulfate (CS) is a linear and sulfated polysaccharide that belongs to the glycosaminoglycan family. [1] CS is constituted CS is involved in important biological processes such as central nervous system development [2] and malaria infection. [3] The participation of CS in these processes is mediated by certain oligosaccharide sequences, with particular sulfate distribution, that interact with several protein receptors. [4] For example, CS-E binds to several heparin-binding growth factors and chemokines, [5, 6] playing important roles in the central nervous system. Recent studies indicated that a CS-E tetrasaccharide interacts with midkine, a growth factor that participates in the development and repair of neural tissues. [7] Interestingly, this interaction requires a specific arrangement of sulfate groups since other oligosaccharides, with different sulfation motifs, bind significantly weaker (or do not bind at all) to midkine. A different class of CS, CS-A, has an important role in pregnancy-associated malaria. [8] This subtype of CS binds to P. falciparum erythrocyte membrane protein 1 (PfEMP1), a critical step for the adhesion of Plasmodium falciparum-infected red blood cells to the placenta.
Due to the heterogeneity of the polymer, structurally defined CS oligosaccharides are not easily obtained in sufficient amounts from natural sources. Therefore, well-defined synthetic oligosaccharides are required for the study of CS-protein interactions at the molecular level, the establishment of structure-activity relationships and the evaluation of the potential therapeutic applications and biological activities of this type of compounds.
Despite the recent advances in CS oligosaccharides and analogues synthesis, [7, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] new approaches to the preparation of these molecules are still highly demanded. A careful protecting group design is required to obtain the adequate configuration of the glycosidic bonds and introduce the sulfate groups at defined positions. The choice of the protection for the amino group [20] of the GalNAc units is an important point in this design. Most reported synthesis of CS oligomers employed N-trichloroacetyl galactosamine building blocks. [21] However, the use of this type of units presents some limitations. The formation of stable trichlorooxazoline side products has been reported in glycosidation reactions of 2-deoxy-2-trichloroacetamido donors. [22] [23] [24] Additionally, the final transformation of the 2-trichloroacetamido to the desired 2-acetamido group can be problematic. The basic hydrolysis of multiple trichloroacetamide groups requires very long reaction times [22] and the alternative reduction (using tributylstannane/AIBN or Zn/acetic acid) affords, in some cases, significant amounts of mono-and dichloroacetamide intermediates. [25] [26] [27] For these reasons, we decided to explore the use of new galactosamine monomers that contain a Ntetrachlorophtaloyl (N-TCP) [28, 29] or a N-trifluroacetyl (N-TFA) [30] [31] [32] protecting group for the synthesis of CS oligosaccharides.
We envisioned that the TCP group would be a good alternative for 2-amino protection because this group avoids the formation of stable oxazolines while it strongly favours the formation of the 1,2-trans glycosidic linkage. [20, 33] Moreover, cleavage of the N-TCP moiety does not require the harsh reaction conditions needed for the removal of the analogous N-phthaloyl group. [34] On the other hand, we envisioned that the TFA group could facilitate the final deprotection steps since it can be removed under milder conditions, compared to the trichloroacetyl. This group also ensures high β selectivities in glycosidation reactions. [35, 36] Next, we will describe the results obtained with both types of building blocks. As a first goal, we considered the synthesis of CS tetrasaccharides since it has been demonstrated that tetramers are long enough to interact with several proteins and exhibit biological activity. [7, 9, [37] [38] Results and Discussion
N-TCP galactosamine building blocks for the synthesis of CS oligosaccharides
We prepared novel GalNAc monomers 1 and 2 (Scheme 1) that can be used as glycosyl acceptor and donor, respectively, in coupling reactions with glucuronic acid derivatives to afford CS-like disaccharides. The 4,6-O-benzylidene acetal will allow the selective sulfation of these positions at the end of the synthesis (see below). Tetraacetate 3 [39] was converted into the 4-methoxyphenyl glycoside 4 by treatment with 4-methoxyphenol and BF 3 ·Et 2 O. De-O-acetylation of 4 is not trivial due to the base-sensitive nature of the N-TCP group and the reported formation of methyl glycoside byproducts during the acid-catalyzed hydrolysis of a similar glucosamine derivative. [40] Therefore, de-O-acetylation was carried out under strictly controlled basic conditions to afford, after benzylidenation, compound 1. Donor 2 was prepared from 1 by levulination at position 3, followed by oxidative removal of the 4-methoxyphenyl group with CAN and trichloroacetimidate activation. Then, we studied the utility of 1 and 2 in glycosylation reactions with glucuronic acid moieties to afford fully protected CS disaccharide precursors (Scheme 2). Glucuronic acid trichloroacetimidate 8 [41, 42] was coupled with acceptor 1 to give disaccharide 9 in good yield. After testing different reaction conditions, the best results were obtained with BF 3 ·Et 2 O as catalyst and toluene as solvent. On the other hand, donor 2 was coupled to acceptor 10 [43] to yield disaccharide 11, with the alternative monosaccharide sequence GalNAc-GlcA. In order to introduce an amine-terminated linker at the reducing end of the chain, highly convenient for further conjugation of the final molecules, 11 was transformed into trichloroacetimidate 13. Glycosylation between 13 and 5-(benzyloxycarbonylamino)-1-pentanol afforded the desired disaccharide 14 in good yield.
With these fully protected disaccharides at hand, we then checked the compatibility of the N-TCP group with the deprotection/sulfation steps required for the synthesis of final deprotected CS oligomers. Thus, starting from 14 we successfully prepared disaccharides 15 and 16 that correspond to the sulfation patterns of CS-E and CS-C, respectively (Scheme 3). The benzylidene acetal of 14 was removed using TFA and the resulting diol was extensively sulfated to give 18. Here, the reaction time was significantly decreased (40 min) using microwave heating. [44] The next step was the basic hydrolysis of the ester groups that occurred with concomitant partial hydrolysis of the N-TCP moiety to afford 19. The amide bond in 19 was cleaved by treatment with ethylenediamine in DMF. This reaction only took 90 min using microwave heating. [45, 46] Finally, the amine group of 20 was selectively acetylated and the resulting derivative 21 was hydrogenated to yield CS-E disaccharide 15 in good yield. For the preparation of CS-C dimer 16, diol 17 was heated at 50ºC, under microwave irradiation, in the presence of 2 equiv. of SO 3 ·NMe 3 Next, we attempted the synthesis of longer CS sequences by a 2+2 coupling of disaccharide units. For this purpose, disaccharide 9 was transformed into the corresponding glycosyl acceptor (by delevulination) and donor (by cleavage of the anomeric 4-methoxyphenyl group and trichloroacetimidate formation).
Unfortunately, the 2+2 glycosylation failed and the desired (GlcAGalNAc) 2 tetrasaccharide could not be isolated. Alternatively, we tried the preparation of a (GalNAc-GlcA) 2 tetrasaccharide from compound 11. Similarly, 11 was converted into the corresponding acceptor and donor disaccharides, but the 2+2 condensation of these units failed again. In all these glycosylation trials, most starting glycosyl acceptor was recovered from the reaction mixture.
Synthesis of CS oligomers using N-TFA-protected galactosamine units
For the synthesis of biologically relevant CS tetrasaccharides, we turned our attention to N-TFA-protected GalNAc units. We have previously reported the preparation and use of this type of building blocks for the synthesis of a hybrid chondroitin/dermatan sulfate oligosaccharide, [43] owning both GlcA and L-iduronic acid (IdoA). Coupling between 31 and 32 [43] [47] gave hepta-O-sulfated tetrasaccharide 37. The introduction of the sulfate groups at the desired positions was confirmed by the 1 H and 13 C NMR data that showed the typical downfield shifts for the sulfated positions (Tables 1 and 2 ). Finally, hydrogenolysis of 37 yielded the fully deprotected CS tetramer 38.
NMR analysis confirmed the structure of 38. 1 H and 13 C NMR data are in full agreement with those reported for similar CS derivatives. Table 2 . 13 C-NMR chemical shifts for sulfated positions of compounds 37 and 38 and the corresponding non-sulfated positions of 36. ) interact with L-and P-selectin and several chemokines and heparin-binding growth factors. [6, 49] The chemical synthesis of these structures, containing both GlcA and IdoA, will contribute to determine the role of hybrid sequences in biological processes including stem cell proliferation, neurogenesis and neural network formation. Tetrasaccharide 50 was obtained from disaccharides 39 [43] and 32 (Scheme 6). The protecting groups of 39 were rearranged to produce the E sulfation pattern at the end of the synthesis. 
Fluorescence polarization competition assay
FGF-2 is a heparin-binding protein [50, 51] that also recognizes CS sequences. [5] We finally screened the interactions between FGF-2 and the synthesized water-soluble CS oligosaccharides (15, 16, 38, 50 and the dibenzylated tetrasaccharide precursors 37 and 49). For this purpose, we employed a fluorescence polarization competition assay, previously developed in our group, [43] in which we measured the relative ability of the synthetic CS oligomers to inhibit the interaction between FGF-2 and a fluorescent labelled heparin probe.
Briefly, the fluorescence polarization of samples containing fixed concentrations of protein and fluorescent probe were measured in the presence of the different CS oligosaccharides (Figure 2 ). The binding of a CS oligomer to FGF-2 would displace the fluorescent probe from its complex with the protein, resulting in a decrease of the polarization value. In this experiment we included two control 6 value for 0% inhibition. As shown in Figure 2 , at 25 µM inhibitor concentration, disaccharides 15 and 16 and tetrasaccharides 49 and 50 only showed low inhibitory activity, while compounds 37 and 38 were able to inhibit 47 and 63%, respectively, of the interaction.
However, the inhibitory activities of oversulfated 37 and 38 were lower than those obtained with previously synthesized IdoAcontaining tetrasaccharides 51 and 52 ( Figure 3 ). [43] In summary, these data indicate that oversulfated, non-natural tetrasaccharides angiogenesis. Therefore, the discovery of compounds that inhibit the FGF-2/heparin interaction is an area of great interest. [52, 53] Although the tested compounds displayed modest activities, this experiment gives some interesting data on the structural features for inhibition of heparin binding to FGF-2. Moreover, this assay illustrates the potential of our fluorescence polarization method for the fast comparison of relative inhibitory activities. The residue was purified by column chromatography (hexane- Compound 4 (1.63 g, 2.4 mmol) was dissolved in MeOH (186 mL), and MeONa/MeOH (1M, 3.2 mL) was added. The mixture was stirred at 0ºC for 10 min, and AcOH (15.5 mL) was added. The mixture was stirred at room temperature for 10 min and co-concentrated twice with toluene. The residue was filtered through a silica column (toluene-acetone 2:1) to give 5 (855 mg) and a mixture of partially deacetylated compounds (348 mg). The partially deprotected products were dissolved in MeOH (40 mL) and treated with additional MeONa (0.68 mL of a 1M solution in MeOH) at 0ºC. After stirring for 7 min at 0ºC, AcOH (3.3 mL) was added and the mixture was + .
4,6-O-Benzylidene-2-deoxy-3-O-levulinoyl-2-tetrachlorophthalimido-
α,β-D-galactopyranose (7): CAN (6.65 g, 11.9 mmol) was added at 0ºC to a solution of 6 (2.2 g, 3.0 mmol) in toluene/MeCN/H 2 O (1:6:1; 104 mL).
After stirring for 1 h at 0ºC, the mixture was diluted with EtOAc, washed . 
4-Methoxyphenyl 3-O-(methyl 2,3-di-O-benzoyl-4-O-levulinoyl-β-Dglucopyranosyluronate)-4,6-O-benzylidene-2-deoxy-2-
6.00 (d, 1H, J 1,2 = 6.1 Hz, H-1A), 5.69 (dd, 1H, J 2,3 = 11.3 Hz, J 3,4 = 3.6 Hz
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-

4-O-(2-deoxy-3-O-levulinoyl-2-tetrachlorophthalimido-β-Dgalactopyranosyl)-β-D-glucopyranoside
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-
4-O-(2-deoxy-3-O-levulinoyl-4,6-di-O-sulfo-2-tetrachlorophthalimido-
β-D-galactopyranosyl)-β-D-glucopyranoside] uronate (18): Compound
N-Benzyloxycarbonyl-5-aminopentyl 4-O-(2-acetamido-2-deoxy-4,6-di-
O-sulfo-β-D-galactopyranosyl)-3-O-benzyl-β-D-glucopyranosiduronic
5-aminopentyl 4-O-(2-acetamido-2-deoxy-4,6-di-O-sulfo-β-Dgalactopyranosyl)-β-D-glucopyranosiduronic acid (15):
Benzyl [N-Benzyloxycarbonyl-5-aminopentyl 2-O-benzoyl-3-O-benzyl-
4-O-(2-deoxy-3-O-levulinoyl-6-O-sulfo-2-tetrachlorophthalimido-β-Dgalactopyranosyl)-β-D-glucopyranoside] uronate (22):
1H, J 1,2 = 6.9 Hz, H-1A), 4.25 (dd, 1H, J 5,6a = 8.2 Hz, J 6a,6b = 10.
5-aminopentyl 4-O-(2-acetamido
3-O-(Benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl
O-[3-O-(Benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-β-Dglucopyranosyluronate)-2-deoxy-4,6-di-O-levulinoyl-2-trifluoroacetamido-α,β-D-galactopyranosyl] trichloroacetimidate (31):
Compound 30 (120 mg, 0.11 mmol) was dissolved in dry CH 2 Cl 2 (3 mL) The organic layers were dried (MgSO 4 ), filtered and concentrated in vacuo.
4-Methoxyphenyl
4-Methoxyphenyl 3-O-(methyl
In order to complete the reaction, this residue was dissolved again in dry Py (10 mL) and was added under an argon atmosphere to a flask containing 
O-[3-O-(Methyl
4-Methoxyphenyl
